Overview
Gulsen Demirci practices practicing medicine in Acibadem, Turkey.
Their clinical expertise encompasses Type A Insulin Resistance Syndrome, Acanthosis Nigricans, Melasma, and Kaposi Sarcoma.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Gulsen T. Demirci
Is Gulsen T. Demirci a top-rated expert for Type A Insulin Resistance Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Gulsen T. Demirci is classified as an Experienced expert for Type A Insulin Resistance Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Gulsen T. Demirci participate in research or clinical trials?
Yes. Gulsen T. Demirci has published 12 articles and abstracts on conditions like Type A Insulin Resistance Syndrome. You can view a list of Gulsen T. Demirci's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acanthosis NigricansDemirci isExperienced. Learn about Acanthosis Nigricans.
- Kaposi SarcomaDemirci isExperienced. Learn about Kaposi Sarcoma.
- MelasmaDemirci isExperienced. Learn about Melasma.
- Type A Insulin Resistance Syndrome